|
1
|
Allanore Y, Simms R, Distler O,
Trojanowska M, Pope J, Denton CP and Varga J: Systemic sclerosis.
Nat Rev Dis Primers. 1:150022015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Avouac J, Mogavero G, Guerini H, Drapé JL,
Mathieu A, Kahan A and Allanore Y: Predictive factors of hand
radiographic lesions in systemic sclerosis: A prospective study.
Ann Rheum Dis. 70:630–633. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Koutaissoff S, Vanthuyne M, Smith V, De
Langhe E, Depresseux G, Westhovens R, De Keyser F, Malghem J and
Houssiau FA: Hand radiological damage in systemic sclerosis:
Comparison with a control group and clinical and functional
correlations. Semin Arthritis Rheum. 40:455–460. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lóránd V, Czirják L and Minier T:
Musculoskeletal involvement in systemic sclerosis. Presse Med.
43:e315–e328. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Avouac J, Walker U, Tyndall A, Kahan A,
Matucci-Cerinic M, Allanore Y, Miniati I, Muller A, Iannone F, et
al: Characteristics of joint involvement and relationship with
systemic inflammation in systemic sclerosis: Results from the EULAR
Scleroderma trial and research group (EUSTAR) database. J
Rheumatol. 37:1488–1501. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Johnstone EM, Hutchinson CE, Vail A,
Chevance A and Herrick AL: Acro-osteolysis in systemic sclerosis is
associated with digital ischaemia and severe calcinosis.
Rheumatology (Oxford). 51:2234–2238. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Saavedra MJ, Ambrosio C, Malcata A,
Matucci-Cerinic M and Da Silva JA: Exuberant calcinosis and
acroosteolysis. A diagnostic challenge. Clin Exp Rheumatol. 27(3):
Suppl 54. S55–S58. 2009.
|
|
8
|
Freire V, Bazeli R, Elhai M, Campagna R,
Pessis É, Avouac J, Allanore Y, Drapé JL and Guérini H: Hand and
wrist involvement in systemic sclerosis: US features. Radiology.
269:824–830. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Benitha R, Modi M and Tikly M: Osteolysis
of the cervical spine and mandible in systemic sclerosis: A case
report with computed tomography and mgnetic resonance imaging
findings. Rheumatology (Oxford). 41:1198–1200. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Braun-Moscovici Y, Furst DE, Markovits D,
Rozin A, Clements PJ, Nahir AM and Balbir-Gurman A: Vitamin D,
parathyroid hormone, and acroosteolysis in systemic sclerosis. J
Rheumatol. 35:2201–2205. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Schipani E, Maes C, Carmeliet G and
Semenza GL: Regulation of osteogenesis-angiogenesis coupling by
HIFs and VEGF. J Bone Miner Res. 24:1347–1353. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Beyer C, Schett G, Gay S, Distler O and
Distler JH: Hypoxia. Hypoxia in the pathogenesis of systemic
sclerosis. Arthritis Res Ther. 11:2202009.
|
|
13
|
Ke Q and Costa M: Hypoxia-inducible
factor-1 (HIF-1). Mol Pharmacol. 70:1469–1480. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ivan M, Kondo K, Yang H, Kim W, Valiando
J, Ohh M, Salic A, Asara JM, Lane WS and Kaelin WG Jr: HIFalpha
targeted for VHL-mediated destruction by proline hydroxylation:
Implications for O2 sensing. Science. 292:464–468. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Krock BL, Skuli N and Simon MC:
Hypoxia-induced angiogenesis: Good and evil. Genes Cancer.
2:1117–1133. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Naldini A, Leali D, Pucci A, Morena E,
Carraro F, Nico B, Ribatti D and Presta M: Cutting edge: IL-1beta
mediates the proangiogenic activity of osteopontin-activated human
monocytes. J Immunol. 177:4267–4270. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Reiseter S, Molberg Ø, Gunnarsoson R, Lund
MB, Aaloken TM, Aukrust P, Ueland T, Garen T, Brunborg C, Michelsen
A, et al: Association between circulating endostatin levels and
vascular organ damage in systemic sclerosis and mixed connective
tissue disease: An observational study. Arthritis Res Ther.
17:2312015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Koch S, Tugues S, Li X, Gualandi L and
Claesson-Welsh L: Signal tranduction by vascular endothelial growth
factor receptors. Biochem J. 437:169–183. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Distler O, Distler JH, Scheid A, Acker T,
Hirth A, Rethage J, Michel BA, Gay RE, Müller-Ladner U,
Matucci-Cerinic M, et al: Uncontrolled expression of vascular
endothelial growth factor and its receptors leads to inssuficient
skin angiogenesis in patients with systemic sclerosis. Circ Res.
95:109–116. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Choi JJ, Min DJ, Cho ML, Min SY, Kim SJ,
Lee SS, Park KS, Seo YI, Kim WU, Park SH and Cho CS: Elevated
vascular endothelial growth factor in systemic sclerosis. J
Rheumatol. 30:1529–1533. 2003.PubMed/NCBI
|
|
21
|
Manetti M, Guiducci S, Romano E,
Bellando-Randone S, Lepri G, Bruni C, Conforti ML, Ibba-Manneschi L
and Matucci-Cerinic M: Increased plasma levels of the VEGF165b
splice variant are associated with the severity of nailfold
capillary loss in systemic sclerosis. Ann Rheum Dis. 72:1425–1427.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kim I, Moon SO, Park SK, Chae SW and Koh
GY: Angiopoietin-1 reduces VEGF-stimulated leukocyte adhesion to
endothelial cells by reducing ICAM-1, VCAM-1, and E-selectin
expression. Circ Res. 89:477–479. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Eklund L and Olsen BR: Tie receptors and
their angiopoietin ligands are context-dependent regulators of
vascular remodeling. Exp Cell Res. 312:630–641. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Scharpfenecker M, Fiedler U, Reiss Y and
Augustin HG: The Tie-2 ligand Angiopoietin-2 destabilizes quiescent
endothelium through an internal autocrine loop mechanism. J Cell
Sci. 118:771–780. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Michalska-Jakubus M, Kowal-Bielecka O,
Chodorowska G and Krasowska D: Angiopoietins-1 and −2 are
differentially expressed in the sera of patients with systemic
sclerosis: High angiopoietin-2 levels are associated with greater
severity and higher activity of the disease. Rheumatology (Oxford).
50:746–755. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dunne JV, Keen KJ and Van Eeden SF:
Circulating angiopoetin and Tie-2 levels in systemic sclerosis.
Rheumatol Int. 33:475–484. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Santulli G: Angioprotein-like proteins: A
comprehensive look. Front Endocrinol (Lausanne). 5:42014.PubMed/NCBI
|
|
28
|
Knowles HJ and Athanasou NA: Acute hypoxia
and osteoclast activity: A balance between enhanced resorption and
increased apoptosis. J Pathol. 218:256–264. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Swales C, Athanasou NA and Knowles HJ:
Angiopoietin-like 4 is over-expressed in rheumatoid arthritis
patients: Association with pathological bone resorption. PLoS One.
9:e1095242014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ichimura Y, Asano Y, Akamata K, Aozasa N,
Noda S, Taniguchi T, Toyama T, Sumida H, Sumida H, Kuwano Y, et al:
Serum angiopetin-like protein 3 levels: Possible correlations with
progressive skin sclerosis, digital ulcers and pulmonary vascular
involvement in patients with systemic sclerosis. Acta Derm
Venereol. 94:157–162. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Utting JC, Flanagan AM, Brandao-Burch A,
Orriss IR and Arnett TR: Hypoxia stimulates osteoclast formation
from human peripheral blood. Cell Biochem Funct. 28:374–380. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Niida S, Kondo T, Hiratsuka S, Hayashi S,
Amizuka N, Noda T, Ikeda K and Shibuya M: VEGF receptor 1 signaling
is essential for osteoclast development and bone marrow formation
in colony-stimulating factor 1-deficient mice. Proc Natl Acad Sci
USA. 102:14016–14021. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sipola A, Nelo K, Hautala T, Ilvesaro J
and Tuukkanen J: Endostatin inhibits VEGF-A induced osteoclastic
bone resorption in vitro. BMC Musculoskelet Disord. 7:562006.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Almeida I, Gomes A Olivera, Lima M, Silva
I and Vasconcelos C: Different contributions of angiostatin and
endostatin in angiogensis impairment in systemic sclerosis: A
cohort study. Clin Exp Rheumatol. 16–Fab;2016.(Epub ahead of
print). PubMed/NCBI
|
|
35
|
Dodd JS, Raleigh JA and Gross TS:
Osteocyte hypoxia: A novel mechanotransduction pathway. Am J
Physiol. 277:C598–C602. 1999.PubMed/NCBI
|
|
36
|
Hinoi E, Ochi H, Takarada T, Nakatani E,
Iezaki T, Nakajima H, Fujita H, Takahata Y, Hidano S, Kobayashi T,
et al: Positive regulation of osteoclastic differentiation by
growth differentiation factor 15 upregulated in osteocytic cells
under hypoxia. J Bone Miner Res. 27:938–949. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kim JH, Liu X, Wang J, Chen X, Zhang H,
Kim SH, Cui J, Li R, Zhang W, Kong Y, et al: Wnt signaling in bone
formation and its therapeutic potential for bone diseases. Ther Adv
Musculoskel Dis. 5:13–31. 2013. View Article : Google Scholar
|
|
38
|
Akhmetshina A, Palumbo K, Dees C, Bergmann
C, Venalis P, Zerr P, Horn A, Kireva T, Beyer C, Zwerina J, et al:
Activation of canonical Wnt signaling is required for TGF-β
mediated fibrosis. Nat Commun. 3:7352012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Chen D, Li Y, Zhou Z, Wu C, Xing Y, Zou X,
Tian W and Zhang C: HIF-1α inhibits Wnt signaling pathway by
activating Sost expression in osteoblasts. PLoS One. 8:e659402013.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Dees C, Tomcik M, Zerr P, Akhmetshina A,
Horn A, Palumbo K, Beyer C, Zwerina J, Distler O, Schett G and
Distler JH: Notch signaling regulates fibroblast activation and
collagen release in systemic sclerosis. Ann Rheum Dis.
70:1304–1310. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Canalis E and Zanotti S: Hajdu-Cheney
syndrome: A review. Orphanet J Rare Dis. 9:2002014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Goumans MJ, Liu Z and ten Dijke P:
TGF-beta signaling in vascular biology and dysfunction. Cell Res.
19:116–127. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Riccieri V, Stefanantoni K, Vasile M,
Macrì V, Sciarra I, Iannace N, Alessandri C and Valesini G:
Abnormal plasma levels of different angiogenic molecules are
associated with different clinical manifestations in patients with
systemic sclerosis. Clin Exp Rheumatol. 29(2): Suppl 65. S46–S52.
2011.PubMed/NCBI
|
